Form D · Biotechnology

Intuitive Biosciences, Inc.

Madison, WI · CIK 0001572790

Offering snapshot reported Oct 3, 2019 · SEC filing

Reported sold
$1.22M
Offering amount: $1.22M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 18, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 3, 2019Initial$1,222,441No comparison5SEC filing
Jun 4, 2015Initial$1,333,888No comparison5SEC filing
Aug 20, 2014Initial$486,858No comparison5SEC filing
Apr 12, 2013Initial$572,726No comparison4SEC filing

Offering details

Securities
Equity, Debt, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-350248
A portion of the Total Offering Amount and the Total Amount Sold is comprised of principal and interest from Company-issued convertible promissory notes that were converted into the Company's equity securities.

Source: Form D, filed Oct 3, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Shawn D Guse Director, Executive
Johan Michelsen Director
Harald Nordal Director
Jay R Sekelsky Director
Jason R Smith Director
Craig R Smith Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
918 Deming Way
Madison, WI, 53717